{"schema":"sb.node.v1","id":"sb:e/a51270cc92a0e16be015fb03","kind":"entity","label":{"text":"breast cancer","locale":"en"},"identity":{"anchor":"label:en:breast cancer","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-10T13:13:12.220585+00:00","snapshot":"deploy 0179e3ac7995bc9e92bae3a80f173732f24a5d75"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":252,"separatePublishers":61,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim","receiptsOnTopic":{"state":"measured","share":1,"named":12,"of":12,"basis":"receipts the entity graph keeps whose own headline names the subject, over all receipts it keeps for the subject (the door's measurement; the graph carries none of its own). Only the former are served"}},"admission":{"state":"provisional","reason":"entity graph provenance 'observed'; the node carries no promotion receipt in v1","policy":"EQ-PROMOTION (receipt not carried)"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-04-23","to":"2026-10-08","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0.226: about 77% of mentions carry no typed assertion"]}},"dimensions":{"domains":["auto","precision_medicine"],"activeDays":47,"assertions":{"regulatory-approval":35,"launch-release":7,"election":5,"utterance":5,"meeting-visit":3,"award":1}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":12,"byKind":{"observation":12},"items":[{"id":"sb:o/81698c2dc03c2afde356c910","kind":"observation","label":"STAT · 2026-10-08 · STAT+: Why this startup is taking its AI to predict breast cancer risk directly to patients","url":"https://www.statnews.com/2026/10/08/why-clairity-took-breast-cancer-risk-prediction-ai-directly-to-patients/?utm_campaign=rss"},{"id":"sb:o/fa256addd697b9e1465e512c","kind":"observation","label":"STAT News · 2026-10-08 · Breast cancer can behave differently in older women. This physician is making more tailored treatments a reality","url":"https://www.statnews.com/2026/10/08/breast-cancer-research-older-women-neil-carleton-stat-wunderkind/?utm_campaign=rss"},{"id":"sb:o/6164cd5c9362b09700f9ad34","kind":"observation","label":"medRxiv Oncology · 2026-10-07 · Multimodal Artificial Intelligence Predicts Pathological Response and Prognosis in HER2-Positive Early Breast Cancer Treated with Chemotherapy De-escalation Strategies…","url":"https://www.medrxiv.org/content/10.64898/2026.10.05.26364736v1?rss=1"},{"id":"sb:o/bcf84445989f48a5437cba41","kind":"observation","label":"European Medical Journal · 2026-10-07 · Global Breast Cancer Initiative: Milestones","url":"https://www.emjreviews.com/oncology/news/global-breast-cancer-initiative-milestones/"},{"id":"sb:o/6118c418b7e4dab053c5be12","kind":"observation","label":"FDA · 2026-10-07 · FDA approves tucatinib with trastuzumab and pertuzumab for the maintenance treatment of HER2-positive breast cancer","url":"http://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-tucatinib-trastuzumab-and-pertuzumab-maintenance-treatment-her2-positive-breast-cancer"},{"id":"sb:o/d8e9ce4b494bc12d51ec6daf","kind":"observation","label":"Inside Precision Medicine · 2026-10-07 · Enzyme Biomarker May Predict CDK4/6 Inhibitor Resistance in Breast Cancer","url":"https://www.insideprecisionmedicine.com/topics/oncology/enzyme-biomarker-may-predict-cdk4-6-inhibitor-resistance-in-breast-cancer/"},{"id":"sb:o/6eb5be82715793a005a10316","kind":"observation","label":"European Medical Journal · 2026-10-07 · Brain Network Changes Linked to Cognitive Impairment in Breast Cancer","url":"https://www.emjreviews.com/oncology/news/brain-network-changes-linked-to-cognitive-impairment-in-breast-cancer/"},{"id":"sb:o/3e4d29d7fa121148af17bad7","kind":"observation","label":"Medical Xpress · 2026-10-06 · Most women know about breast cancer risk factors, but fewer act on them","url":"https://medicalxpress.com/news/2026-10-women-breast-cancer-factors.html"},{"id":"sb:o/029b3d60d0ceab7c4d7a4e88","kind":"observation","label":"Frontiers Precision Oncology · 2026-10-06 · Integrated CDK4/6 inhibitor resistance and primary-metastatic discordance in hormone receptor-positive/HER2-negative metastatic breast cancer: a translatio…","url":"https://www.frontiersin.org/articles/10.3389/fonc.2026.1918231"},{"id":"sb:o/13bcf158611f71047d78b3d6","kind":"observation","label":"The Hindu · 2026-10-06 · Early screening, timely treatment key to beating breast cancer, says Collector Nishant Krishna","url":"https://www.thehindu.com/news/cities/Madurai/early-screening-timely-treatment-key-to-beating-breast-cancer-says-collector-nishant-krishna/article71551345.ece"}],"cursor":"c1.eyJpZCI6InNiOmUvYTUxMjcwY2M5MmEwZTE2YmUwMTVmYjAzIiwibCI6ImNoaWxkcmVuIiwibyI6MTAsImsiOm51bGwsImEiOiIyMDI2LTEwLTEwVDEzOjEzOjEyLjIyMDU4NSswMDowMCJ9","order":"newest first; we keep the 12 newest receipts for this entity whose own headline names it. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":10,"byKind":{"co-mentioned":10},"items":[{"kind":"relation","label":"co-mentioned with studie (76 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/a8c5f19397cde9cac90992f2"},{"kind":"relation","label":"co-mentioned with fda (74 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/401d11272a73849fd4990b2f"},{"kind":"relation","label":"co-mentioned with her2 (71 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/0000a9d810182f4106c351f3"},{"kind":"relation","label":"co-mentioned with ai (62 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/65cf5c65ed7924f20ccecc88"},{"kind":"relation","label":"co-mentioned with lung cancer (53 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/44cde3a5ef1ffaf7e8dd3f01"},{"kind":"relation","label":"co-mentioned with immunotherapy (53 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/0972419aeb1c73d8409fabc3"},{"kind":"relation","label":"co-mentioned with clinical trials (40 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/2859565373e46c4b115d8bf8"},{"kind":"relation","label":"co-mentioned with her2-negative (40 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/4bcdf50d43e01ab3aae8b148"},{"kind":"relation","label":"co-mentioned with united states (39 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/26ec9decfadf80d9e5d1dda6"},{"kind":"relation","label":"co-mentioned with size (37 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/cd12389edaac483519f58328"}],"cursor":null,"order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/a51270cc92a0e16be015fb03","mcp":"traverse {\"id\":\"sb:e/a51270cc92a0e16be015fb03\"}","page":"/entity/breast-cancer/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/a51270cc92a0e16be015fb03\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/a51270cc92a0e16be015fb03\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"cantina","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/a51270cc92a0e16be015fb03\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"cantina","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/a51270cc92a0e16be015fb03\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"cantina","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history (EQ-REPLAY), which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"cantina","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"cantina","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"workshop","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"docking-bay","reason":"one-time Reads are parked until the Commander decides their shape (#938)"}]}